Page 32 - TD-1-2

Tumor Discovery Prognostic biomarkers in pancreatic cancer

https://doi.org/10.1200/PO.21.00084 with the proportion of regulatory T cells by weighted
gene co-expression network analysis in uterine corpus
24. Allgauer M, Budczies J, Christopoulos P, et al., 2018,
Implementing tumor mutational burden (TMB) analysis in endometrial carcinoma. Front Immunol, 12: 788431.
routine diagnostics-a primer for molecular pathologists and https://doi.org/10.3389/fimmu.2021.788431
clinicians. Transl Lung Cancer Res, 7(6): 703–715.
26. Mayer P, Gaida MM, 2021, The microarchitecture of
https://doi.org/10.21037/tlcr.2018.08.14 pancreatic cancer from the point of view of the pathologist
and the radiologist. Pathologe, 42(5): 524–529.
25. Liu J, Geng R, Yang S, et al., 2021, Development and clinical
validation of novel 8-gene prognostic signature associated https://doi.org/10.1007/s00292-021-00949-2

Volume 1 Issue 2 (2022) 15 https://doi.org/10.36922/td.v1i2.165